NovaBridge Biosciences (NBP)
NASDAQ: NBP · Real-Time Price · USD
2.390
-0.040 (-1.65%)
At close: Apr 28, 2026, 4:00 PM EDT
2.580
+0.190 (7.95%)
After-hours: Apr 28, 2026, 7:59 PM EDT
NovaBridge Biosciences Employees
NovaBridge Biosciences had 30 employees as of December 31, 2025. The number of employees decreased by 2 or -6.25% compared to the previous year.
Employees
30
Change (1Y)
-2
Growth (1Y)
-6.25%
Revenue / Employee
n/a
Profits / Employee
-$2,944,667
Market Cap
276.40M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Cellectis | 229 |
| Coherus Oncology | 147 |
| AC Immune | 122 |
| C4 Therapeutics | 104 |
| Artiva Biotherapeutics | 104 |
| Editas Medicine | 87 |
| Compugen | 75 |
| Cybin | 50 |
NBP News
- 6 days ago - NovaBridge Appoints Mark Hagler as President and Chief Commercial Officer to Advance Commercial Strategy and Maximize Pipeline Value - GlobeNewsWire
- 21 days ago - NovaBridge Reports Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 6 weeks ago - NovaBridge Announces Productive FDA Type B Meeting on Potential Accelerated Approval Pathway for Givastomig in Gastric Cancer - GlobeNewsWire
- 7 weeks ago - Mid-Cap NovaBridge Biosciences Stock Jumps Fueled By Positive Study Data In Eye Disease - Benzinga
- 7 weeks ago - NovaBridge and Visara Announce Positive Results from VIS-101 Phase 2a Wet AMD Study - GlobeNewsWire
- 2 months ago - NovaBridge to Host Business Update Call to Review Phase 2a Data for VIS-101 in Wet AMD on Monday, March 9, 2026 - GlobeNewsWire
- 2 months ago - NovaBridge to Present at the Leerink Partners 2026 Global Healthcare Conference - GlobeNewsWire
- 2 months ago - NovaBridge Appoints Biotech Leader, Emmett T. Cunningham, Jr, MD, PhD, MPH, as Vice Chairman of the Board to Further Accelerate Global Biotech Platform - GlobeNewsWire